Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $100,388 - $145,794
740 New
740 $113,000
Q3 2021

Nov 05, 2021

SELL
$221.9 - $484.47 $849,877 - $1.86 Million
-3,830 Closed
0 $0
Q2 2021

Jul 28, 2021

SELL
$129.91 - $234.98 $168,883 - $305,474
-1,300 Reduced 25.34%
3,830 $900,000
Q1 2021

May 10, 2021

BUY
$109.18 - $185.98 $560,093 - $954,077
5,130 New
5,130 $672,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Axs Investments LLC Portfolio

Follow Axs Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axs Investments LLC with notifications on news.